Home LiteratureArticle Details
PMID: 6642669 Published · ppublish English Comparative Study Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Dermal granulomatous hypersensitivity in Q fever: comparative studies of the granulomatous potential of whole cells of Coxiella burnetii phase I and subfractions.

Infection and immunity ·Vol. 42 ·No. 3 ·1983-12-00 ·Pages 887-9

Ascher MS, Williams JC, Berman MA

Abstract

Dermal granulomatous reactivity to Q fever antigens in guinea pigs has been described as a model for vaccine reactions seen in previously sensitized humans. This model has now been applied to study the ability of subfractions of Coxiella burnetii to produce granulomas. Q fever organisms in phase I, trichloroacetic acid-soluble and -insoluble fractions, and the extract and residue of chloroform-methanol extraction were tested for their relative ability to elicit and immunize for dermal granulomatous reactions and specific lymphocyte proliferative responses in guinea pigs. The results suggest that a determinant(s) causing granulomas can be removed by chloroform-methanol extraction of phase I whole cells. The chloroform-methanol residue elicited strong delayed-type hypersensitivity without subsequent granuloma formation. The chloroform-methanol residue appears to possess a determinant(s) for lymphocyte stimulation equivalent to that of whole phase I organisms.

MeSH Terms
Animals Coxiella/immunology Dermatitis, Atopic/immunology Female Granuloma/immunology Guinea Pigs Immunization In Vitro Techniques Lymphocyte Activation/drug effects Lymphocytes/immunology Q Fever/immunology Skin/immunology Skin Tests
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Ascher M S
Williams J C
Berman M A
References (8)
8 references, click to expand
  1. A microagglutination technique for detection and measurement of rickettsial antibodies.
    Acta Virol. 1969 Jan;13(1):60-6 PMID: 4387631
  2. Preparation of phase 1Q fever antigen suitable for vaccine use.
    Appl Environ Microbiol. 1976 Jul;32(1):85-8 PMID: 970938
  3. Q-fever soluble vaccine effects in Coxiella burneti sensitized humans.
    Zentralbl Bakteriol Orig A. 1977 Jul;238(3):413-8 PMID: 910580
  4. CONVERSION OF THE PHASE I ANTIGEN OF COXIELLA BURNETII TO HAPTEN BY PHENOL TREATMENT.
    J Bacteriol. 1963 May;85:1165-70 PMID: 14044011
  5. Biological and immunological properties of Coxiella burnetii vaccines in C57BL/10ScN endotoxin-nonresponder mice.
    Infect Immun. 1982 Mar;35(3):1091-102 PMID: 7068212
  6. Experimental model for dermal granulomatous hypersensitivity in Q fever.
    Infect Immun. 1983 Jan;39(1):388-93 PMID: 6822420
  7. Initial clinical and immunologic evaluation of a new phase I Q fever vaccine and skin test in humans.
    J Infect Dis. 1983 Aug;148(2):214-22 PMID: 6350491
  8. Mechanisms of protective immunogenicity of microbial vaccines: effects of cyclophosphamide pretreatment in Venezuelan encephalitis, Q fever and tularaemia.
    Clin Exp Immunol. 1980 Aug;41(2):225-36 PMID: 7438552
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1983-12-00
Pages
887-9
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC264382
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com